The team of Professor Zhao Gang, chairman of the Yinfeng Cryomedicine Expert Committee, and his collaborators published a report [Cryopreservation method of mouse follicles based on synergistic ice suppression effect]
Release time:
2022-12-27
In recent years, the incidence of malignant diseases (such as breast cancer and hematological diseases) among young women has increased. Although aggressive chemoradiotherapy or bone marrow transplantation can cure 90% of young women, these treatments can still damage their gonads. It can even lead to premature ovarian failure. In addition, many women who delay childbearing due to work or financial reasons are also affected by infertility. Therefore, the demand for fertility preservation among women is increasing dramatically. Currently, methods for preserving female fertility mainly include cryopreservation of embryos, unfertilized oocytes and ovarian tissue. Among them, embryo cryopreservation requires women to have a male partner or use donated sperm, which may involve religious, moral, ethical and other issues. Oocyte cryopreservation is mainly used for women who have reached puberty and can withstand multiple rounds of ovarian stimulation. For adult women and unmarried female cancer patients, follicle cryopreservation is almost their only option.
In fertility research, mouse preantral follicles (PAFs) are often used as a model to optimize cryopreservation, in vitro culture conditions, and fertility preservation. Common follicle cryopreservation methods include slow freezing and vitrification. The former will inevitably form a large number of ice crystals, which will then cause irreversible damage to the follicles; the latter, in order to achieve the glass transition of the sample and avoid ice crystal damage, needs to introduce a very high concentration of cryoprotectant (usually 6M), which will cause greater Large chemical toxicity damage. In addition, recrystallization and/or devitrification may occur during the rewarming and melting process, which is often fatal to the damage to the sample. In summary, the preservation of follicles poses a great challenge to cryobiologists. How to achieve safe and efficient vitrification preservation of low-concentration, low-toxic or even non-toxic cryoprotectants?
Zhao Gang, chairman of the Yinfeng Cryomedicine Expert Committee, and his team developed a vitrification method for the preservation of mouse follicles with a low-concentration cryoprotectant based on the synergistic ice-suppressing effect. They combined magnetothermal and photothermal space rewarming with hydrogel microencapsulation to achieve synergistic ice suppression, reducing the concentration of the osmotic protective agent by 75% (only 1.5M). Among them, space rewarming technology uses the dual thermal effects of magnetothermal and photothermal to effectively improve the rewarming rate and temperature distribution uniformity, solve the problem of devitrification/recrystallization that may occur during the heating process, and avoid excessive cell damage. Hydrogel microencapsulation can not only provide a protective barrier for cells, reduce extracellular ice damage, and prevent the growth of intracellular ice nuclei; it can also effectively reduce the toxic and side effects during the vitrification process by reducing the growth of ice crystals during cooling and heating. The need for protective agents; it can also provide a three-dimensional microenvironment similar to the extracellular matrix for in vitro PAFs culture, which strongly supports the in vitro development of 3D cultured mouse follicles after rewarming. After cryopreservation, the survival rate of PAFs is as high as 90%; and mature oocytes can be successfully discharged after 13 days of 3D culture in vitro. These mature oocytes develop to the blastocyst stage after in vitro fertilization, and the fertilized eggs are in the 2-cell Early transplantation into surrogate mice can give birth to healthy mouse pups.
In summary, this study successfully established a technical system that integrates microencapsulation, freezing, rewarming and 3D culture, opening up a new path for cryopreservation and full utilization of PAFs, which may help improve post-treatment outcomes. The patient's chance of regaining fertility. Additionally, the method could potentially be used to preserve female germ cells from high-risk animal species, spurring the creation and development of cryobanks in medical centers around the world.
As a forward-looking field of human medical research, cryogenic medicine cannot be separated from the joint efforts of scientific research teams from all parties. The international cryogenic biomedical research system organized and led by the Yinfeng cryogenic medicine team will build an academic exchange and achievement sharing platform for global cryogenic biomedical research teams, integrate international and domestic scientific research academic forces in multiple fields, and build a systematic cryogenic medical research system. Jointly promote the development of cryogenic medicine research and let global cryogenic medicine researchers gather into a powerful force of organic synergy.
Previous article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
